Victor Greiff is cofounder & Chief Technology Officer at IMPRINT. He has 15 years of expertise in developing machine learning, computational, and experimental tools for analyzing antibody and T cell repertoires, with a focus on facilitating in silico design of immune receptor-based diagnostics and therapeutics. A thought leader in the AI immune repertoire space, Dr. Greiff has co-authored over 90 papers, collaborates widely across industry and academia, has previously served as the Chair of the AIRR Community, and serves on the boards of numerous antibody companies. Dr. Greiff is also a Professor of Systems Immunology at the University of Oslo (Department of Immunology). He earned his Ph.D. from Humboldt University Berlin, Germany, and conducted postdoctoral research in the laboratory of Sai T. Reddy at ETH Zürich, Switzerland. In 2023, he was awarded a prestigious European Research Council (ERC) Consolidator Grant - among Europe’s most competitive research awards - to develop computational approaches for deciphering the antigen-specific language of adaptive immunity.